CVE:QPT Quest PharmaTech (QPT) Stock Price, News & Analysis → Could Your Accounts Be Frozen? (From Allegiance Gold) (Ad) Free QPT Stock Alerts C$0.02 -0.01 (-33.33%) (As of 05/3/2024 05:24 PM ET) Add Compare Share Share Today's RangeC$0.02▼C$0.0250-Day RangeC$0.02▼C$0.0452-Week RangeC$0.02▼C$0.11Volume14,000 shsAverage Volume48,153 shsMarket CapitalizationC$3.38 millionP/E RatioN/ADividend Yield6.15%Price TargetN/A Stock AnalysisStock AnalysisChartEarningsHeadlinesInsider TradesStock AnalysisChartEarningsHeadlinesInsider Trades Get Quest PharmaTech alerts: Email Address Ad Allegiance GoldCould Your Accounts Be Frozen?The US Dollar Is "Finished" A deteriorating economy, global instability, and a weakened banking system have pushed the U.S. financial system to the brink, imperiling the value of your savings and investments.Get your Free Wealth Protection Kit About Quest PharmaTech Stock (CVE:QPT)Quest PharmaTech Inc., a pharmaceutical company, engages in the development of novel therapeutics for the treatment of targeted cancer. Its lead product candidate is Mab AR 9.6 against truncated O-glycan on MUC16, for targeted cancer therapy applications. The company also offers Oregovomab, which is in Phase III clinical trial for the treatment of ovarian cancer. In addition, it develops, manufactures, and commercializes immunotherapy products for pancreatic cancer; and combinatorial immunotherapeutic products for the treatment cancer by using monoclonal antibodies of the immunoglobulin of G and E class. Quest PharmaTech Inc. is headquartered in Edmonton, Canada.Read More QPT Stock Price History View Price History Chart DataSkip Price History Chart 30 days | 90 days | 365 days | Advanced Chart QPT Stock News HeadlinesMay 5, 2024 | americanbankingnews.comQuest PharmaTech (CVE:QPT) Reaches New 12-Month Low at $0.02February 20, 2024 | theglobeandmail.comQuest PharmaTech: Top 10 Undervalued Healthcare Sector Stocks on TSX-V (QPT)May 5, 2024 | Colonial Metals (Ad)The Gold Grab of the CenturyWhen central banks buy gold… The rich buy right along with them. And central banks are buying at breakneck pace. Last year… 1,037 tons. Just 45 tons less than the record set two years ago.February 20, 2024 | theglobeandmail.comPsyBio Therapeutics: Top 10 Undervalued Healthcare Sector Stocks on TSX-V (PSYB)February 19, 2024 | theglobeandmail.comMarvel Biosciences: Top 10 Undervalued Biotechnology Industry Stocks (MRVL)February 6, 2024 | finance.yahoo.comQuest PharmaTech Inc. (QPT.V)January 30, 2024 | ca.finance.yahoo.comQuest Receives Cash Dividend Payment from OncoQuestJanuary 21, 2024 | theglobeandmail.comQuest PharmaTech: Top 10 Undervalued Biotechnology Industry Stocks (QPT)May 5, 2024 | Colonial Metals (Ad)The Gold Grab of the CenturyWhen central banks buy gold… The rich buy right along with them. And central banks are buying at breakneck pace. Last year… 1,037 tons. Just 45 tons less than the record set two years ago.January 2, 2024 | cnet.comBest Meta Quest 2 Accessories for 2024November 6, 2023 | theglobeandmail.comClosing Bell: Quest Pharmatech Inc up on Thursday (QPT)October 14, 2023 | theglobeandmail.comClosing Bell: Quest Pharmatech Inc flat on Thursday (QPT)September 29, 2023 | theglobeandmail.comClosing Bell: Quest Pharmatech Inc down on Tuesday (QPT)September 16, 2023 | time.comMeta Quest Promo CodesAugust 24, 2023 | theglobeandmail.comClosing Bell: Quest Pharmatech Inc up on Tuesday (QPT)August 17, 2023 | ca.finance.yahoo.comQPT.V - Quest PharmaTech Inc.August 5, 2023 | theglobeandmail.comClosing Bell: Quest Pharmatech Inc flat on Monday (QPT)July 10, 2023 | finance.yahoo.comQuest PharmaTech Provides Product Development UpdateJune 7, 2023 | finance.yahoo.comCanadian Investment Regulatory Organization Trade Resumption - QPTJune 6, 2023 | finance.yahoo.comQuest PharmaTech Clarifies Agreement in Principle with OQP Bio Inc.June 6, 2023 | finance.yahoo.comCanadian Investment Regulatory Organization Trading Halt - QPTMay 13, 2023 | theglobeandmail.comClosing Bell: Quest Pharmatech Inc down on Thursday (QPT)May 4, 2023 | theglobeandmail.comClosing Bell: Quest Pharmatech Inc flat on Tuesday (QPT)April 27, 2023 | theglobeandmail.comClosing Bell: Quest Pharmatech Inc flat on Wednesday (QPT)April 22, 2023 | theglobeandmail.comClosing Bell: Quest Pharmatech Inc flat on Friday (QPT)April 19, 2023 | theglobeandmail.comClosing Bell: Quest Pharmatech Inc down on Monday (QPT)January 26, 2023 | reuters.comQPT.V - | Stock Price & Latest News | ReutersSee More Headlines Receive QPT Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Quest PharmaTech and its competitors with MarketBeat's FREE daily newsletter. Email Address Company Calendar Today5/05/2024Next Earnings (Estimated)7/04/2024Get Stock AlertsIndustry, Sector and Symbol Stock ExchangeCVE SectorMedical Industry Biotechnology Sub-IndustryN/A Current SymbolCVE:QPT CUSIPN/A CIKN/A Webwww.questpharmatech.com Phone+1-780-4481400FaxN/AEmployees147,000Year FoundedN/AProfitability EPS (Most Recent Fiscal Year)C($0.12) Trailing P/E RatioN/A Forward P/E RatioN/A P/E GrowthN/ANet IncomeC$-22,260,000.00 Net MarginsN/A Pretax MarginN/A Return on Equity-28.86% Return on Assets-0.94% Debt Debt-to-Equity Ratio1.51 Current Ratio0.26 Quick Ratio0.52 Sales & Book Value Annual SalesC$38,871.00 Price / Sales87.02 Cash FlowC$0.00 per share Price / Cash Flow20.00 Book ValueC$0.39 per share Price / Book0.05Miscellaneous Outstanding Shares169,130,000Free FloatN/AMarket CapC$3.38 million OptionableNot Optionable Beta0.29 The Next 7 Blockbuster Stocks for Growth InvestorsWondering what the next stocks will be that hit it big, with solid fundamentals? Click the link below to learn more about how your portfolio could bloom.Get This Free Report Key ExecutivesDr. Ragupathy Madiyalakan Ph.D.CEO & DirectorMr. Pierre Vermette C.A.CPA, Chief Financial OfficerMr. Roger AndrewsHead of Investor Relations & Corporate CommunicationsMr. Douglas C. Bachman (Age 70)Vice President of Corporate Development Comp: $37.94kMr. Thomas WooVice President of Product DevelopmentKey CompetitorsRevive TherapeuticsCVE:RVVInnovotechCVE:IOTHemostemixCVE:HEMPacgen Life Science Co. (PBS.V)CVE:PBSMedifocus Inc. (MFS.V)CVE:MFSView All CompetitorsInsidersRagupathy MadiyalakanBought 15,290 shares on 9/15/2023Total: C$1,070.30 ($0.07/share)Ragupathy MadiyalakanBought 30,000 shares on 8/29/2023Total: C$2,100.00 ($0.07/share)Ragupathy MadiyalakanBought 20,000 shares on 8/25/2023Total: C$1,400.00 ($0.07/share)View All Insider Transactions QPT Stock Analysis - Frequently Asked Questions How have QPT shares performed in 2024? Quest PharmaTech's stock was trading at C$0.06 on January 1st, 2024. Since then, QPT shares have decreased by 63.6% and is now trading at C$0.02. View the best growth stocks for 2024 here. When is Quest PharmaTech's next earnings date? The company is scheduled to release its next quarterly earnings announcement on Thursday, July 4th 2024. View our QPT earnings forecast. What other stocks do shareholders of Quest PharmaTech own? Based on aggregate information from My MarketBeat watchlists, some companies that other Quest PharmaTech investors own include Indiva (NDVA), CME Group (CME) and How do I buy shares of Quest PharmaTech? Shares of QPT stock and other Canadian stocks can be purchased through an online brokerage account. Popular online brokerages with access to the Canadian stock market include BMO InvestorLine, CIBC Investor's Edge, Desjardins Online Brokerage, HSBC InvestDirect, Laurentian Bank Discount Brokerage, National Bank Direct Brokerage, Qtrade Investor, Questrade, RBC Direct Investing, Scotia iTrade, TD Direct Investing, and Virtual Brokers.Compare Top Brokerages Here. This page (CVE:QPT) was last updated on 5/5/2024 by MarketBeat.com Staff From Our PartnersConflict In Israel Sends Gold Soaring ???? Here’s How To Get Your ShareColonial MetalsElon to Transform U.S. Economy? Porter & CompanyCould Your Accounts Be Frozen?Allegiance GoldGlobal crypto currency reset (41 major banks signed up)Stansberry ResearchMissed NVDA? Buy this AI stock NOWChaikin AnalyticsDid You Get Your Free Bitcoin Yet?Crypto Swap ProfitsThe A.I. story nobody is telling you (Read ASAP)TradeSmithRSVP: Charles Payne’s Cash Flow WorkshopUnstoppable Prosperity Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Quest PharmaTech Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
